Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A controlled trial of the drug tranexamic acid (TXA) in inpatients recently admitted to the hospital with the diagnosis of COVID19. It is hypothesized that TXA will reduce the infectivity and virulence of the virus.
Epistemonikos ID: 2c2bb3771aca634d001f3c64682052751780f2b2
First added on: Apr 09, 2020